The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.

Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE

Original Publication: Oxford, UK : Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies, c2005-

Models, Molecular* ; Virus Internalization*/drug effects; HIV Envelope Protein gp120/*metabolism ; HIV Envelope Protein gp41/*metabolism ; HIV Fusion Inhibitors/*metabolism ; HIV-1/*drug effects ; Peptide Fragments/*metabolism ; Peptides/*metabolism; Amino Acid Substitution ; CD4 Antigens/chemistry ; CD4 Antigens/metabolism ; Enfuvirtide ; HEK293 Cells ; HIV Envelope Protein gp120/antagonists & inhibitors ; HIV Envelope Protein gp120/chemistry ; HIV Envelope Protein gp120/genetics ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/pharmacology ; HIV Fusion Inhibitors/chemistry ; HIV Fusion Inhibitors/pharmacology ; HIV-1/physiology ; Humans ; Hydrophobic and Hydrophilic Interactions ; Kinetics ; Ligands ; Magnetic Resonance Spectroscopy ; Mutation ; Peptide Fragments/chemistry ; Peptide Fragments/genetics ; Peptide Fragments/pharmacology ; Peptides/chemistry ; Peptides/genetics ; Peptides/pharmacology ; Protein Interaction Domains and Motifs ; Recombinant Proteins/chemistry ; Recombinant Proteins/metabolism ; Recombinant Proteins/pharmacology ; Solubility ; Surface Plasmon Resonance

The peptide T20, which corresponds to a sequence in the C-terminal segment of the HIV-1 transmembrane glycoprotein gp41, is a strong entry inhibitor of HIV-1. It has been assumed that T20 inhibits HIV-1 infection by binding to the trimer formed by the N-terminal helical region (HR1) of gp41, preventing the formation of a six helix bundle by the N- and C-terminal helical regions of gp41. In addition to binding to gp41, T20 was found to bind to gp120 of X4 viruses and this binding was suggested to be responsible for an alternative mechanism of HIV-1 inhibition by this peptide. In the present study, T20 also was found to bind R5 gp120. Using NMR spectroscopy, the segments of T20 that interact with both gp120 and a gp120/CD4M33 complex were mapped. A peptide corresponding to the fourth constant region of gp120, sC4, was found to partially recapitulate gp120 binding to T20 and the segment of this peptide interacting with T20 was mapped. The present study concludes that an amphiphilic helix on the T20 C-terminus binds through mostly hydrophobic interactions to a nonpolar gp120 surface formed primarily by the C4 region. The ten- to thousand-fold difference between the EC50 of T20 against viral fusion and the affinity of T20 to gp120 implies that binding to gp120 is not a major factor in T20 inhibition of HIV-1 fusion. Nevertheless, this hydrophobic gp120 surface could be a target for anti-HIV therapeutics.
(© 2015 FEBS.)

J Virol. 2000 Sep;74(18):8358-67. (PMID: 10954535)
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24. (PMID: 12370423)
Biochemistry. 2002 Oct 22;41(42):12687-96. (PMID: 12379111)
Nat Biotechnol. 2003 Jan;21(1):71-6. (PMID: 12483221)
AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1207-17. (PMID: 12487827)
Blood. 2004 Feb 15;103(4):1211-7. (PMID: 14576050)
Virology. 2003 Oct 10;315(1):124-34. (PMID: 14592765)
J Virol. 2004 Apr;78(7):3742-52. (PMID: 15016894)
J Virol. 2004 May;78(10):5448-57. (PMID: 15113923)
AIDS Res Hum Retroviruses. 2004 Aug;20(8):836-45. (PMID: 15320988)
J Virol. 2004 Oct;78(19):10724-37. (PMID: 15367639)
J Biol Chem. 2005 Mar 25;280(12):11259-73. (PMID: 15640162)
Immunity. 2005 Feb;22(2):163-73. (PMID: 15723805)
Biochemistry. 2005 Oct 18;44(41):13602-11. (PMID: 16216084)
Science. 2005 Nov 11;310(5750):1025-8. (PMID: 16284180)
Biochemistry. 2008 Jul 1;47(26):6782-92. (PMID: 18540633)
Methods Mol Biol. 2009;524:37-57. (PMID: 19377935)
Curr Opin Struct Biol. 2009 Aug;19(4):473-82. (PMID: 19632107)
Trends Biochem Sci. 2009 Dec;34(12):601-11. (PMID: 19846313)
Virology. 2010 Jun 5;401(2):293-304. (PMID: 20347111)
PLoS Pathog. 2010 May 06;6(5):e1000880. (PMID: 20463810)
J Mol Biol. 2011 Jul 29;410(5):778-97. (PMID: 21763489)
J Biol Chem. 2012 Apr 27;287(18):15076-86. (PMID: 22403408)
FEBS J. 2014 Jul;281(13):3019-31. (PMID: 24819826)
Nat Chem Biol. 2014 Oct;10(10):845-52. (PMID: 25174000)
Proteins. 2015 Feb;83(2):331-50. (PMID: 25401969)
Expert Opin Ther Pat. 2015 Feb;25(2):159-73. (PMID: 25428639)
FEBS J. 2015 May;282(10):1906-1921. (PMID: 25703038)
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788. (PMID: 29711196)
Proc Natl Acad Sci U S A. 1984 Oct;81(19):6019-23. (PMID: 6237367)
AIDS Res Hum Retroviruses. 1993 Nov;9(11):1051-3. (PMID: 8312047)
Biochemistry. 1996 Oct 22;35(42):13697-708. (PMID: 8885850)
J Virol. 1998 Feb;72(2):986-93. (PMID: 9444991)
Cell. 1998 May 29;93(5):681-4. (PMID: 9630213)
Science. 1998 Jun 19;280(5371):1949-53. (PMID: 9632396)
Nature. 1998 Jun 18;393(6686):648-59. (PMID: 9641677)

R01 GM022087 United States GM NIGMS NIH HHS; R01 GM053329 United States GM NIGMS NIH HHS; GM53329 United States GM NIGMS NIH HHS; GM22087 United States GM NIGMS NIH HHS; R56 GM022087 United States GM NIGMS NIH HHS

Keywords: CCR5; HIV-1 inhibitors; NMR; T20; gp120

0 (CD4 Antigens)
0 (CD4M33 peptide)
0 (HIV Envelope Protein gp120)
0 (HIV Envelope Protein gp41)
0 (HIV Fusion Inhibitors)
0 (Ligands)
0 (NN-T20-NITN peptide)
0 (Peptide Fragments)
0 (Peptides)
0 (Recombinant Proteins)
0 (gp120 protein, Human immunodeficiency virus 1)
19OWO1T3ZE (Enfuvirtide)

Date Created: 20151004 Date Completed: 20160524 Latest Revision: 20190109

20240829

PMC4715528

10.1111/febs.13541

26432362